News
-
-
COMMUNIQUÉ DE PRESSE
83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Jaguar Health's Canalevia-CA1 receives FDA approval for chemotherapy-induced diarrhea in dogs, addressing a critical unmet need in veterinary oncology -
-
COMMUNIQUÉ DE PRESSE
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies to feature interviews with bioAffinity Technologies, Inc. and Can-Fite BioPharma Ltd. on Bloomberg TV's Small Stocks, Big Money™ show this Saturday. Companies discuss innovative therapies and milestones -
-
-
COMMUNIQUÉ DE PRESSE
SES and SpeQtral Sign MoU to Advance Global Quantum-Secure Communications
SES and SpeQtral sign MoU to develop global Quantum-Secure Communications with an interoperable Optical Ground Station linking Asia and Europe. Collaboration aims to advance quantum-secure networks and services -
COMMUNIQUÉ DE PRESSE
Two of LQR House Stockholders, Including Its CEO, Enter Lock-up Agreement Covering at Least 209,543 Shares
LQR House Inc. announced 12-month lock-up agreements signed by stockholders including its CEO to cover 209,543 shares, promoting market stability for the alcohol e-commerce platform -
-
COMMUNIQUÉ DE PRESSE
Atlas Salt Provides Comprehensive Development Update on Great Atlantic Salt Project
Atlas Salt Inc. provides updates on key workstreams for the Great Atlantic Salt Project including project financing discussions with Endeavour, engineering and mine plan updates, geotechnical and hydrogeological drilling program progress, and project governance and execution planning
